Can a special rehab program help more amputees walk again?

NCT ID NCT07665775

Not yet recruiting Knowledge-focused Sponsor: Instituto Nacional de Rehabilitacion Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a hospital rehab and prosthetic training program helps people who lost a leg due to diabetes or blood vessel disease use their artificial limb regularly. Researchers will review past patient records and follow new patients for up to 6 months after they leave the hospital. The goal is to see how many people use their prosthetic at least 8 hours a day and score well on a mobility test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multidisciplinary inpatient rehabilitation and prosthetic training program
What this could lead to: If successful, this could show that a structured rehab program helps more people with leg amputations use their prosthetic regularly, improving mobility and quality of life.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other settings or countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus peripheral arterial disease thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS PERIPHERAL ARTERIAL DISEASE TRANSFEMORAL AMPUTATION VASCULAR THROMBOSIS

Contacts and locations

Locations

Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra

Mexico City, Mexico City, 14389, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.